CN Patent

CN107602564B — 布鲁顿酪氨酸激酶抑制剂

Assigned to Yaojie Ankang (Nanjing) Technology Co.,Ltd. · Expires 2019-08-30 · 7y expired

What this patent protects

本发明涉及式I结构的化合物或其药学上可接受的盐、溶剂化物、活性代谢物、多晶型物、酯、光学异构体或前药，包含式I结构的化合物的药物组合物及其作为选择性布鲁顿酪氨酸激酶的抑制剂用于制备预防或治疗异种免疫性疾病、自身免疫性疾病或癌症的药物的用途。

USPTO Abstract

本发明涉及式I结构的化合物或其药学上可接受的盐、溶剂化物、活性代谢物、多晶型物、酯、光学异构体或前药，包含式I结构的化合物的药物组合物及其作为选择性布鲁顿酪氨酸激酶的抑制剂用于制备预防或治疗异种免疫性疾病、自身免疫性疾病或癌症的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN107602564B
Jurisdiction
CN
Classification
—
Expires
2019-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Yaojie Ankang (Nanjing) Technology Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.